维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

8篇 您的检索式：作者名="Mangiola M"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	lnhibitors of XIAP sensitize CD40-activated chronic lymphocytic leukemia cells to CD95-mediated apoptosis 显示文摘	Kater AP Dicker F Mangiola M	2005	Blood2005，106，5：	1
	2	Early evaluation of cerebral metabolic rate of glucose (CMRglu) with (18)F-FDG PET/CT and clinical assessment in idiopathic normal pressure hydrocephalus (INPH) patients before and after ventricular shunt placement:preliminary experience显示文摘	CALCAGNI ML LAVALLE M MANGIOLA A		0，，02：	1
	3	Regulation of the p27 (Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation显示文摘	leSage C Nagel R Egan D A Schrier M Mesman E Mangiola A		0，，：	1
	4	Gliomatosis cerebri and pituitary adenoma: case report and literature review显示文摘	Mangiola A De Bonis P Guerriero M	2005	J Neuroon- col2005，74，：	1
	5	Inhibitors of XIAP sensitize CD40-activated chronic lymphocytic leukemia cells to CD95-mediated apoptosis显示文摘	Dicker F Mangiola M	2005	Blood2005，106，5：	1
	6	m-THPC-mediated photodynamic therapy of malignant gliomas:assessment of a new trandection strategy显示文摘	Calcabrini A Colone M Mangiola A	2007	Int J Cancer2007，121，：	1
	7	Extensive modulation of a set of microRNAs in pri mary glioblastoma显示文摘	Ciafre S A Galardi S Mangiola A Ferracin M Liu C G Sabati no G	2005	Biochem Biophys Res Commun2005，334，：	1
	8	High-grade glioma:elderly patients,older treatments显示文摘Patients aged 65 years or older represent half of all patients with glioblastoma.Nonetheless,this older cohort is often excluded from trials.The NOA-08 Phase III trial compared radiotherapy(RT)(60 Gy) versus temozolomide(TMZ;100 mg/m(2)) in the elderly patients(65 years and older) with high-grade glioma.Median overall survival was comparable between the two groups(8.6RT-and 9.6-TMZ-months).Resection extent was the only independent prognostic factor for overall survival.Several concerns arise: the inclusion of patients with a very low Karnofsky Performance Status(KPS;KPS = 20),the lack of an analysis of the impact of KPS and comorbidities on outcome,the salvage therapy administered at tumor progression(RT in the TMZ group and TMZ in the RT group),which could have balanced the effects of primary treatments,the absence of information on spread of disease/tumor site,the mixture of grade III and grade IV histologies.Ongoing trials evaluating RT plus TMZ,RT plus bevacizumab and other treatment modalities in the elderly population are going to change clinical practice in the near future.	De Bonis P Mangiola A Pompucci A Porso M Anile C	2013	中国神经肿瘤杂志2013，11，1：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费